Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Zed1227
1. Zed-1227
2. 1542132-88-6
3. T4sr539ykf
4. Zed1227
5. Tak-227
6. Methyl (e,6s)-7-[[1-[2-(2-ethylbutylamino)-2-oxoethyl]-2-oxopyridin-3-yl]amino]-6-[(3-methylimidazole-4-carbonyl)amino]-7-oxohept-2-enoate
7. Methyl (e,6s)-7-((1-(2-(2-ethylbutylamino)-2-oxoethyl)-2-oxopyridin-3-yl)amino)-6-((3-methylimidazole-4-carbonyl)amino)-7-oxohept-2-enoate
8. Refchem:195896
9. Unii-t4sr539ykf
10. Chembl4081588
11. Methyl (s,e)-7-((1-(2-((2-ethylbutyl)amino)-2-oxoethyl)-2-oxo-1,2-dihydropyridin-3-yl)amino)-6-(1-methyl-1h-imidazole-5-carboxamido)-7-oxohept-2-enoate
12. (2e,6s)-7-((1-(2-((2-ethylbutyl)amino)-2-oxoethyl)-1,2-dihydro-2-oxo-3-pyridinyl)amino)-6-(((1-methyl-1h-imidazol-5-yl)carbonyl)amino)-7-oxo-2-heptenoic Acid Methyl Ester
13. Methyl (e,6s)-7-((1-(2-(2-ethylbutylamino)-2-oxo-ethyl)-2-oxo-3-pyridyl)amino)-6-((3-methylimidazole-4-carbonyl)amino)-7-oxo-hept-2-enoate
14. (2e,6s)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1h-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoic Acid Methyl Ester
15. 2-heptenoic Acid, 7-((1-(2-((2-ethylbutyl)amino)-2-oxoethyl)-1,2-dihydro-2-oxo-3-pyridinyl)amino)-6-(((1-methyl-1h-imidazol-5-yl)carbonyl)amino)-7-oxo-, Methyl Ester, (2e,6s)-
16. 2-heptenoic Acid, 7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1h-imidazol-5-yl)carbonyl]amino]-7-oxo-, Methyl Ester, (2e,6s)-
17. Methyl (2e,6s)-7-((1-(2-((2-ethylbutyl)amino)-2-oxoethyl)-1,2-dihydro-2-oxo-3-pyridinyl)amino)-6-(((1-methyl-1h-imidazol-5-yl)carbonyl)amino)-7-oxo-2-heptenoate
18. Methyl (2e,6s)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1h-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoate
19. Glutaminase
20. Vilagletistat [inn]
21. Orb1706443
22. Schembl16751074
23. Ex-a7845r
24. Gtpl12802
25. (2e,6s)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1h-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoicacidmethylester
26. Bdbm50245478
27. Akos040742843
28. Hy-19359
29. Ms-29784
30. Cs-0015432
31. G15912
32. (2e,6s)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1h-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoic Acid Methyl Ester; (2e,6s)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1h-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoic Acid Methyl Ester
| Molecular Weight | 528.6 g/mol |
|---|---|
| Molecular Formula | C26H36N6O6 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 15 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 152 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 958 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of Vilagletistat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vilagletistat manufacturer or Vilagletistat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vilagletistat manufacturer or Vilagletistat supplier.
A Vilagletistat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vilagletistat, including repackagers and relabelers. The FDA regulates Vilagletistat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vilagletistat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vilagletistat supplier is an individual or a company that provides Vilagletistat active pharmaceutical ingredient (API) or Vilagletistat finished formulations upon request. The Vilagletistat suppliers may include Vilagletistat API manufacturers, exporters, distributors and traders.
Vilagletistat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vilagletistat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Vilagletistat GMP manufacturer or Vilagletistat GMP API supplier for your needs.
A Vilagletistat CoA (Certificate of Analysis) is a formal document that attests to Vilagletistat's compliance with Vilagletistat specifications and serves as a tool for batch-level quality control.
Vilagletistat CoA mostly includes findings from lab analyses of a specific batch. For each Vilagletistat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vilagletistat may be tested according to a variety of international standards, such as European Pharmacopoeia (Vilagletistat EP), Vilagletistat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vilagletistat USP).
